Shire PLC (SHP) Rating Reiterated by BNP Paribas


's stock had its "outperform" rating reissued by investment analysts at BNP Paribas in a report issued on Sunday, StockTargetPrices.com reports. They presently have a GBX 5,900 price target on the biopharmaceutical company's stock.



from Biotech News